Ticker

Using Shareholder-Approved Plan to Incentivize and Retain MISSISSAUGA, ON / ACCESS Newswire / February 24, 2026 / Microbix Biosystems Inc. (TSX:MBX)(OTCQX:MBXBF) (Microbix®), a life sciences innovator, manufacturer, and exporter, announces the issuance of stock options under its shareholder-approved stock option plan (the "Stock Option Plan"), as part of its compensation programs to incentivize and retain its board…

Microbix Biosystems Inc. (MBX:CA) Q1 2026 Earnings Call Transcript

Q1 Revenues of $4.2 million and Controlled Net Loss MISSISSAUGA, ON / ACCESS Newswire / February 12, 2026 / Microbix Biosystems Inc. (TSX:MBX)(OTCQX:MBXBF, Microbix® ), a life sciences innovator, manufacturer, and exporter, reports results for its first quarter of fiscal 2026 ended December 31, 2025 ("Q1"). Results for Q1 demonstrated the Company's efforts to rebuild revenues back above its breakeven point following…

MISSISSAUGA, ON / ACCESS Newswire / February 10, 2026 / Microbix Biosystems Inc. (TSX:MBX)(OTCQX:MBXBF) (Microbix®), a life sciences innovator, manufacturer, and exporter, is pleased to welcome the College of America Pathologists ("CAP") as a customer for Microbix quality assessment products ("QAPs™") for use in CAP clinical laboratory proficiency-testing ("PT") programs, also commonly known as External Quality…

Results Release and Webinar Discussion on Morning of February 12, 2026 MISSISSAUGA, ON / ACCESS Newswire / February 5, 2026 / Microbix Biosystems Inc. (TSX:MBX)(OTCQX:MBXBF)(Microbix® ), a life sciences innovator, manufacturer, and exporter, announces that it expects to file the financial statements, management disclosure and analysis, and results news release for its first quarter of fiscal 2026 ended December 31,…